Erratum: The role of the mitochondrial protein VDAC1 in inflammatory bowel disease: a potential therapeutic target (Molecular Therapy (2022) 30(2) (726–744), (S1525001621003543), (10.1016/j.ymthe.2021.06.024))

Ankit Verma, Srinivas Pittala, Belal Alhozeel, Anna Shteinfer-Kuzmine, Ehud Ohana, Rajeev Gupta, Jay H. Chung, Varda Shoshan-Barmatz

Research output: Contribution to journalComment/debate

1 Scopus citations

Abstract

(Molecular Therapy 30, 726–744; February 2022) In the originally published version of this article, there was an unintentional mistake in Figure 4E due to overlapping in the frame. It was discovered after the authors carefully checked the original data. These images were mistakenly inserted into Figure 4E due to carelessness while uploading final figures for formal production. The authors apologize deeply for any trouble these inadvertent errors may have caused the editors and readers. The corrected figure is provided below.[Formula

Original languageEnglish
Pages (from-to)1178
Number of pages1
JournalMolecular Therapy
Volume32
Issue number4
DOIs
StatePublished - 3 Apr 2024

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pharmacology
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Erratum: The role of the mitochondrial protein VDAC1 in inflammatory bowel disease: a potential therapeutic target (Molecular Therapy (2022) 30(2) (726–744), (S1525001621003543), (10.1016/j.ymthe.2021.06.024))'. Together they form a unique fingerprint.

Cite this